HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodies (Q34477471)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodies	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodies (English)

1 reference

Europe PubMed Central

2 August 2017

HIV transmission

0 references

1 reference

based on heuristic

inferred from title

Clelia Palladino

object named as

Clelia Palladino

28

0 references

Flavia Ferrantelli

object named as

Flavia Ferrantelli

8

0 references

Claudia Andreini

object named as

Claudia Andreini

6

0 references

Ilaria Schiavoni

object named as

Ilaria Schiavoni

18

0 references

Ilaria Bacigalupo

object named as

Ilaria Bacigalupo

19

0 references

Barbara Ridolfi

object named as

Barbara Ridolfi

29

0 references

Stefania Bellino

object named as

Stefania Bellino

13

0 references

Orietta Picconi

object named as

Orietta Picconi

14

0 references

Cecilia Sgadari

object named as

Cecilia Sgadari

34

0 references

Fabrizio Ensoli

object named as

Fabrizio Ensoli

41

0 references

object named as

Paolo Monini

1

0 references

object named as

Barbara Ensoli

44

0 references

38

object named as

Lucia Banci

1 reference

Europe PubMed Central

2 August 2017

object named as

Mario Falchi

30

0 references

40

object named as

Rino Rappuoli

1 reference

Europe PubMed Central

2 August 2017

object named as

Iole Macchia

31

1 reference

ORCID Public Data File 2021

35

object named as

Mauro Magnani

1 reference

Europe PubMed Central

2 August 2017

author name string

Aurelio Cafaro

2

1 reference

Europe PubMed Central

2 August 2017

Indresh K Srivastava

3

1 reference

Europe PubMed Central

2 August 2017

Sonia Moretti

4

1 reference

Europe PubMed Central

2 August 2017

Victoria A Sharma

5

1 reference

Europe PubMed Central

2 August 2017

Chiara Chiozzini

7

1 reference

Europe PubMed Central

2 August 2017

Maria R Pavone Cossut

9

1 reference

Europe PubMed Central

2 August 2017

Antonella Tripiciano

10

1 reference

Europe PubMed Central

2 August 2017

Filomena Nappi

11

1 reference

Europe PubMed Central

2 August 2017

Olimpia Longo

12

1 reference

Europe PubMed Central

2 August 2017

Emanuele Fanales-Belasio

15

1 reference

Europe PubMed Central

2 August 2017

Alessandra Borsetti

16

1 reference

Europe PubMed Central

2 August 2017

Elena Toschi

17

1 reference

Europe PubMed Central

2 August 2017

Elaine Kan

20

1 reference

Europe PubMed Central

2 August 2017

Leonardo Sernicola

21

1 reference

Europe PubMed Central

2 August 2017

Maria T Maggiorella

22

1 reference

Europe PubMed Central

2 August 2017

Katy Montin

23

1 reference

Europe PubMed Central

2 August 2017

Marco Porcu

24

1 reference

Europe PubMed Central

2 August 2017

Patrizia Leone

25

1 reference

Europe PubMed Central

2 August 2017

Pasqualina Leone

26

1 reference

Europe PubMed Central

2 August 2017

Barbara Collacchi

27

1 reference

Europe PubMed Central

2 August 2017

Jeffrey B Ulmer

32

1 reference

Europe PubMed Central

2 August 2017

Stefano Buttò

33

1 reference

Europe PubMed Central

2 August 2017

Maurizio P M Federico

36

1 reference

Europe PubMed Central

2 August 2017

Fausto Titti

37

1 reference

Europe PubMed Central

2 August 2017

Franco Dallocchio

39

1 reference

Europe PubMed Central

2 August 2017

Susan W Barnett

42

1 reference

Europe PubMed Central

2 August 2017

Enrico Garaci

43

1 reference

Europe PubMed Central

2 August 2017

language of work or name

0 references

publication date

13 November 2012

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

7

1 reference

Europe PubMed Central

2 August 2017

e48781

1 reference

Europe PubMed Central

2 August 2017

11

1 reference

Europe PubMed Central

2 August 2017

copyright license

Creative Commons Attribution 4.0 International

13 November 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Impact of viral dose and major histocompatibility complex class IB haplotype on viral outcome in mauritian cynomolgus monkeys vaccinated with Tat upon challenge with simian/human immunodeficiency virus SHIV89.6P

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Targeting early infection to prevent HIV-1 mucosal transmission.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Innovative approaches to develop prophylactic and therapeutic vaccines against HIV/AIDS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

The preventive phase I trial with the HIV-1 Tat-based vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhe

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Generation and characterization of a stable cell population releasing fluorescent HIV-1-based Virus Like Particles in an inducible way.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Role of V1V2 and other human immunodeficiency virus type 1 envelope domains in resistance to autologous neutralization during clade C infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Immune cell migration in inflammation: present and future therapeutic targets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Structure of a V3-containing HIV-1 gp120 core

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

The Amber biomolecular simulation programs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

The V1, V2, and V3 regions of the human immunodeficiency virus type 1 envelope differentially affect the viral phenotype in an isolate-dependent manner

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Structure of an unliganded simian immunodeficiency virus gp120 core

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Cell surface-associated Tat modulates HIV-1 infection and spreading through a specific interaction with gp120 viral envelope protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Integrins and angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Nonstructural HIV proteins as targets for prophylactic or therapeutic vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

HIV-1 tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

ClusPro: a fully automated algorithm for protein-protein docking

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Purification, Characterization, and Immunogenicity of a Soluble Trimeric Envelope Protein Containing a Partial Deletion of the V2 Loop Derived from SF162, an R5-Tropic Human Immunodeficiency Virus Type 1 Isolate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

HADDOCK: a protein-protein docking approach based on biochemical or biophysical information

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Homonuclear (1)H-NMR assignment and structural characterization of human immunodeficiency virus type 1 Tat Mal protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Inflammation, immune reactivity, and angiogenesis in a severe combined immunodeficiency model of rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Native HIV-1 Tat protein targets monocyte-derived dendritic cells and enhances their maturation, function, and antigen-specific T cell responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Efficient gene transduction by RGD-fiber modified recombinant adenovirus into dendritic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

1H-13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Maturation-dependent expression and function of the CD49d integrin on monocyte-derived human dendritic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Comparative analysis of integrin expression on monocyte-derived macrophages and monocyte-derived dendritic cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

A third-generation lentivirus vector with a conditional packaging system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Effect of major deletions in the V1 and V2 loops of a macrophage-tropic HIV type 1 isolate on viral envelope structure, cell entry, and replication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Comparative protein modelling by satisfaction of spatial restraints

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Recovery of HIV-related retroviruses from Italian patients with AIDS or AIDS-related complex and from asymptomatic at-risk individuals.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

6 July 2018

SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccine.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0048781

21 January 2018

Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P).

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0048781

21 January 2018

Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0048781

21 January 2018

Containment of infection in tat vaccinated monkeys after rechallenge with a higher dose of SHIV89.6P(cy243).

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0048781

21 January 2018

Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0048781

21 January 2018

HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0048781

21 January 2018

Immobilized HIV-1 Tat protein promotes gene transfer via a transactivation-independent mechanism which requires binding of Tat to viral particles

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0048781

21 January 2018

Antibodies against full-length Tat protein and some low-molecular-weight Tat-peptides correlate with low or undetectable viral load in HIV-1 seropositive patients.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0048781

21 January 2018

The presence of anti-Tat antibodies is predictive of long-term nonprogression to AIDS or severe immunodeficiency: findings in a cohort of HIV-1 seroconverters

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0048781

21 January 2018

A combination HIV vaccine based on Tat and Env proteins was immunogenic and protected macaques from mucosal SHIV challenge in a pilot study.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0048781

21 January 2018

Inhibition of HIV-1 replication by a Tat transdominant negative mutant in human peripheral blood lymphocytes from healthy donors and HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0048781

21 January 2018

Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0048781

21 January 2018

The modulation of dendritic cell integrin binding and activation by RGD-peptide density gradient substrates

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0048781

21 January 2018

Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0048781

21 January 2018

Innate anti-viral immunity is associated with the protection elicited by the simian immunodeficiency virus (SIV) live attenuated virus vaccine in cynomolgus monkeys.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

27 October 2018

BiGGER: a new (soft) docking algorithm for predicting protein interactions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

27 October 2018

The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496724

27 October 2018

The therapeutic phase I trial of the recombinant native HIV-1 Tat protein

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0048781

21 January 2018

Monocyte-derived dendritic cells and monocytes migrate to HIV-Tat RGD and basic peptides

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0048781

21 January 2018

Vaccines based on the native HIV Tat protein and on the combination of Tat and the structural HIV protein variant ΔV2 Env

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate–containing RGD peptide liposomes inhibits experimental arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Candidate HIV-1 Tat vaccine development: from basic science to clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibodies to Tat and Vpr in the GRIV cohort: differential association with maintenance of long-term non-progression status in HIV-1 infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of retroviral vectors for the analysis of SIV/HIV-specific CD8 T cell responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individuals

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human blood dendritic cells: binding to vascular endothelium and expression of adhesion molecules

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0048781

1 reference

Europe PubMed Central

2 August 2017

2012PLoSO...748781M

0 references

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34477471&oldid=1866219418"